NCT04423055View on ClinicalTrials.gov

Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

April 9, 2024

Study Completion Date

April 9, 2024

Conditions
Contraception
Interventions
DRUG

Etonogestrel contraceptive implant

Place etonogestrel contraceptive implant.

Trial Locations (3)

19104

University of Pennsylvania, Philadelphia

80045

University of Colorado, Denver

95817

University of California, Davis, Sacramento

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Pennsylvania

OTHER

lead

University of California, Davis

OTHER

NCT04423055 - Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive | Biotech Hunter | Biotech Hunter